Susan Laura Smith

Insider Reports History

Entity
Individual
Location
5 Overlook Ct, Lambertville, NJ
Signature
/s/ John LaRocca, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Susan Laura Smith:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Y-mAbs Therapeutics, Inc. SVP & CHIEF COMMERCIAL OFFICER Common Stock 33.9K $561K $16.55 Mar 5, 2024 Direct
Y-mAbs Therapeutics, Inc. SVP & CHIEF COMMERCIAL OFFICER Employee Stock Option (right to buy) 35.7K Jan 18, 2024 Direct

Insider Reports Filed by Susan Laura Smith

Symbol Company Period Transactions Value $ Form Type Date Filed Role
YMAB Y-mAbs Therapeutics, Inc. Mar 5, 2024 1 -$27.8K 4 Mar 7, 2024 SVP & CHIEF COMMERCIAL OFFICER
YMAB Y-mAbs Therapeutics, Inc. Jan 18, 2024 2 $0 4 Jan 22, 2024 SVP & CHIEF COMMERCIAL OFFICER
YMAB Y-mAbs Therapeutics, Inc. Jan 26, 2023 1 $0 4 Jan 30, 2023 SVP & CHIEF COMMERCIAL OFFICER
YMAB Y-mAbs Therapeutics, Inc. Jan 17, 2023 2 $0 4 Jan 19, 2023 SVP & CHIEF COMMERCIAL OFFICER
YMAB Y-mAbs Therapeutics, Inc. Apr 26, 2022 1 $0 4 Apr 28, 2022 SVP & CCO
YMAB Y-mAbs Therapeutics, Inc. Dec 14, 2021 1 $0 4 Dec 23, 2021 SVP & CCO
YMAB Y-mAbs Therapeutics, Inc. Dec 14, 2021 0 $0 3 Dec 23, 2021 Senior Vice President, CCO